Lettmann Jason 4
4 · ALX ONCOLOGY HOLDINGS INC · Filed Feb 16, 2024
Insider Transaction Report
Form 4
Lettmann Jason
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Common Stock
2024-02-14+60,000→ 167,220 total - Award
Employee Stock Option
2024-02-14+190,000→ 190,000 totalExercise: $15.84Exp: 2034-02-13→ Common Stock (190,000 underlying)
Footnotes (2)
- [F1]The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on August 14, 2024.
- [F2]Shares subject to the option vest in 48 equal monthly installments beginning on March 14, 2024.